Á¦ 20 ȸ ´ëÇѳú¿°/³ú¿°ÁõÇÐȸ Ãß°èÇмú´ëȸ : 2023-12-09
±³À°ÀÏÀÚ : 2023-12-09
±³À°Àå¼Ò : ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦
±³À°ÁÖÁ¦ : Á¦ 20 ȸ ´ëÇѳú¿°/³ú¿°ÁõÇÐȸ Ãß°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѽŰæ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѳú¿°/³ú¿°ÁõÇÐȸ
´ã´çÀÚ : ÁÖÁöÇö
¿¬¶ôó : 02-2072-0629
À̸ÞÀÏ : encephalitis.office@kens.or.kr
±³À°Á¾·ù : ½Å°æ°ú
Âü¼®¿¹»óÀÎ : 80¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 12¿ù 09ÀÏ ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 09:00~09:30 ÇöÀåµî·Ï ()
±³À°½Ã°£ 12¿ù 09ÀÏ ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 09:30~09:50 A trial of Vagal Nerve Stimulation therapy in autoimmune epilepsy È«»óºó(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 12¿ù 09ÀÏ ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 09:50~10:10 General approach to NORSE, a case-based review ±è¿ë¹«(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 12¿ù 09ÀÏ ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 10:10~10:30 Autoimmune limbic encephalitis combined with leptomeningeal metastases of Non-small cell lung cancer À̼³¾Æ(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 12¿ù 09ÀÏ ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 10:30~10:50 Chronic cryptococcal meningitis with a cryptococcoma presenting as normal pressure hydrocephalus: a case report ½ÅÁ¤¿ø(ºÐ´çÂ÷º´¿ø)
±³À°½Ã°£ 12¿ù 09ÀÏ ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 10:50~11:10 A case of hyperacute postvaccinal encephalopathy after BNT162b2 nCoV-19 vaccine ±è±¤±â(µ¿±¹´ëÀϻ꺴¿ø)
±³À°½Ã°£ 12¿ù 09ÀÏ ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 11:10~11:30 Otogenic Enterobacter cloacae meningitis complicated with pneumocephalus À̼ҷ¡(°ºÏ»ï¼ºº´¿ø)
½Ä»ç 12¿ù 09ÀÏ ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 11:30~12:40 LUNCH ()
±³À°½Ã°£ 12¿ù 09ÀÏ ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 12:40~13:20 Autoimmune antibody tests in Mayo Clinic Lab Jaron Z. Liu(Mayo Clinic Laboratories)
±³À°½Ã°£ 12¿ù 09ÀÏ ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 13:20~14:00 Diagnosis of Autoimmune Encephalitis ÁÖ°Ç(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 12¿ù 09ÀÏ ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 14:00~14:40 Encephalitis and BBB MR imaging ÃÖ½ÂÈ«(¼¿ï´ëº´¿ø)
ÈÞ½Ä 12¿ù 09ÀÏ ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 14:40~15:00 COFFEE BREAK ()
±³À°½Ã°£ 12¿ù 09ÀÏ ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 15:00~15:20 Encephalitis Journal¿¡ Åõ°íµÈ Àú³Î ¼Ò°³ ¹× ÇöȲ º¸°í ¹Ú°æÀÏ(¼¿ï´ëº´¿ø °³²¼¾ÅÍ)
±³À°½Ã°£ 12¿ù 09ÀÏ ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 15:20~15:45 Disease spectrum and immunotherapy response of Cryptogenic New-Onset Refractory Status Epilepticus (C-NORSE) ¾È¼öÇö(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 12¿ù 09ÀÏ ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 15:45~16:10 Immune dysregulation in anti-NMDA receptor encephalitis ½Å¿ë¿ø(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 12¿ù 09ÀÏ ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 16:10~16:35 Risk factors and clinical manifestations of PNES in autoimmune encephalitis ¾È¼±Àç(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 12¿ù 09ÀÏ ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 16:35~17:00 Progressive multifocal leukoencephalopathy ÀÌÇÑ»ó(¼¿ï´ëº´¿ø)